HeyJaredPediatr Allergy Immunol
- Indexed articles, last 90 days
- 4
- Latest publication
- Sep 24, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Aug 25, 2026
Latest articles
Taste Aversion Drives Kids Off OIT as Often as Reactions (opens the original)
Read excerpt
In a real-world cohort of children undergoing oral immunotherapy (OIT) for food allergies, 15% of treatment courses were discontinued, with rates varying across allergens. Taste aversion and adverse events contributed almost equally to discontinuation, each accounting for approximately 40% of discontinued treatment courses. "Improving real-world OIT outcomes will require patient-centered protocols that systematically address sensory, psychological, and logistical barriers alongside immunological
Food Allergy Remains Rare at Age 5 Post-Lockdown Birth (opens the original)
Read excerpt
Food allergy continued to be uncommon at age 5 in children born in Dublin during Ireland's first COVID lockdown. Sensitization to airborne allergens increased from age 2 to age 5, whereas atopic dermatitis declined, and wheeze prevalence remained stable. "We propose that lockdown-associated early-life environmental and lifestyle changes including higher breastfeeding rates, lower antibiotic exposure and early allergenic food introduction…may have altered early risk for food allergy, a benefit th
Venom Immunotherapy Safe in Pediatric Hymenoptera Allergy (opens the original)
Read excerpt
Venom immunotherapy demonstrated a favorable safety profile, with low rates of adverse reactions, and provided sustained protection against severe systemic reactions in children and adolescents with Hymenoptera venom allergy. "VIT [Venom immunotherapy] is confirmed as the only treatment able to modify the natural history of HVA [Hymenoptera venom allergy], protecting patients with IgE-mediated allergies from systemic reactions after subsequent stings and improving patients' quality of life," the
Biphasic Anaphylaxis More Common in Younger Infants (opens the original)
Read excerpt
Anaphylaxis in infants and young toddlers presents with age-specific symptoms — pallor, hypotonia, persistent crying — that differ from older children, complicating timely recognition, with cardiovascular signs predicting those at risk for a second anaphylactic reaction. "While a 4-hour observation period seems sufficient for most infants/toddlers experiencing anaphylaxis, greater severity, cardiovascular signs and/or fluid resuscitation may be useful predictors of biphasic/recurrent anaphylaxis
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.